Table 2.
Sex male/female | 13/33 |
Age at diagnosis (years, median) | 40 (7–69) |
Age at onset (years, median) | 16.5 (1–69) |
Consanguinity | 13 (28%) |
Family history | 10 (22%) |
Past history of NSAIDs useb | 2 (4.5%) |
NSAIDs use at diagnosisc | 0 (0%) |
History of H. pylori infectiond | 5 (24%) |
Symptoms | |
Anemia | 45 (98%) |
Abdominal pain | 18 (39%) |
Edema | 11 (24%) |
Diarrhea | 2 (4%) |
Hematemesis | 1 (2%) |
Hematochezia | 1 (2%) |
Laboratory data at diagnosis | |
Hemoglobin (g/dl, median) | 9.6 (2.3–13.7) |
Serum protein (g/dl, median) | 5.2 (2.7–8.2) |
CRP (mg/dl, median) | 0.20 (0–1.6) |
Surgery | 29 (63%) |
Extra-intestinal manifestations | |
Digital clubbinga | 10 (22%) |
Periostosisa,e | 11 (25%) |
Acroosteolysise | 1 (2%) |
Arthralgia of large joints | 7 (15%) |
Knee-joint effusions | 4 (9%) |
Hyperhidrosis | 4 (9%) |
Pachydermiaa | 8 (17%) |
Seborrhea | 3 (7%) |
Acne | 7 (15%) |
Flushing | 4 (9%) |
Patent ductus arteriosus | 1 (2%) |
Delayed cranial suture closure | 0 |
aThese manifestations are included in the major clinical criteria for PHO
Data are available for b 44, c 45, and d 21 patients, respectively
eData are available for 44 patients with X-ray evaluation